Medifast (MED) Tops Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.49 +3.14%
Financial Fact:
Income before income taxes: 9.01M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Financial Fact:
Income before income taxes: 9.01M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of ($0.21), $0.09 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $89.4 million versus the consensus estimate of $93.8 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- National Research Corporation (NRC) Reports In-Line Q3 EPS
- OrthoPediatrics (KIDS) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
